<DOC>
	<DOCNO>NCT02173860</DOCNO>
	<brief_summary>The purpose study determine whether , patient undergo elective valvular heart surgery , revascularization concomitant coronary artery disease ( CAD ) guide FFR ( Fractional flow reserve ) would superior standard angiography-guided-revascularization approach major efficacy safety outcome</brief_summary>
	<brief_title>Strategies Revascularization Patients Undergoing Heart Valve Surgery With Concomitant Coronary Artery Disease</brief_title>
	<detailed_description>The SAVE-IT trial multicenter , international , randomize , control , superiority trial . Patients schedule undergo elective valvular heart surgery screen presence concomitant coronary artery disease ( CAD ) invasive coronary angiography . Patients stenosis &gt; 50 % least one epicardial vessel ( exclude left main ) consider suitable surgical revascularization randomize FFR guided- standard angiography-guided surgical revascularization . A proportion patient concomitant CAD follow parallel registry Baseline clinical , laboratory , electrocardiographic echocardiographic data obtain . Coronary anatomy severity assess quantitative coronary angiography ( QCA ) Synergy Percutaneous Coronary Intervention Taxus Cardiac Surgery ( Syntax ) score . Surgical risk assess Euroscore . Patients randomize FFR-guided arm functional severity angiographic stenosis assess St. Jude Medical coronary pressure wire measurement hyperemic condition use intravenous intracoronary adenosine administration . If FFR â‰¤0.8 graft place distal coronary stenosis . If FFR &gt; 0.8 grafting perform epicardial vessel contain stenosis . Patients receive cardiac surgery later 8 week randomization . Peri-operative data collect . Clinical follow-up data collect 1 , 6 12 month surgery . Graft patency 12 month assess cardiac compute angiography ( CCTA ) patient receive least one graft , except invasive coronary angiography perform precede 3 month base clinical ground .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>Age &gt; 18 year Severe heart valve disease indication elective cardiac St. Jude Medical Heart Valve Concomitant significant CAD ( least one epicardial vessel stenosis &gt; 50 % ) Willing able provide inform write consent Previous CABG Angiographic significant lesion involve leave main lesion ( patient still eligible right coronary artery candidate FFR measurement surgical revascularization ) All lesion extremely tortuous calcify coronary vessel Recent myocardial infarction ( &lt; 30 day ) Cardiogenic shock clinical instability ( i.e . NYHA 4 , uncontrolled arrhythmia , unexplained hypotension severe bradycardia medical condition consider sign instability assist physician ) Severe leave ventricular dysfunction ( EF &lt; 35 % ) Pregnant plan become pregnant duration investigation Chronic renal dysfunction define estimate glomerular filtration rate &lt; 60 ml/min Life expectancy &lt; 12 month Currently participate clinical investigation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Coronary artery disease</keyword>
	<keyword>Valvular heart disease</keyword>
	<keyword>Fractional flow reserve</keyword>
	<keyword>Coronary artery bypass surgery</keyword>
	<keyword>Coronary graft failure patency</keyword>
</DOC>